Special Issue "Vaccine Efficacy and Vaccine Effectiveness"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 42755
Interests: vaccines clinical research & development; vaccine efficacy; vaccine effectiveness; vaccine public health impact; epidemiology of vaccine preventable disease; field epidemiology
This special issue will look at the evaluation of vaccine efficacy for different vaccines and at the existing relationship between efficacy and effectiveness. According the mode of transmission of the pathogen or the level of vaccine efficacy of a given vaccine or the vaccine coverage achieved the effectiveness may vary and influence the impact of the vaccine at population level.
Dr. Simonetta Viviani
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine efficacy
- vaccine effectiveness
- vaccine direct and indirect effect (i.e., Herd Immunity)